MICHELLE LOVELACE: Open Payments
NPI 1609446475 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 37 payments from 11 companies in 2025. Trend: 2023 $850 · 2024 $770 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 7 | $294 |
| Astellas Pharma US Inc | 2 | $140 |
| ViiV Healthcare Company | 1 | $121 |
| Novo Nordisk Inc | 6 | $115 |
| Exact Sciences Corporation | 5 | $88 |
| Abbott Laboratories | 4 | $86 |
| Lilly USA, LLC | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| SHIELD THERAPEUTICS INC | 1 | $34 |
| PFIZER INC. | 2 | $34 |
Products named: Dexcom G6 Transmitter, DEXCOM G7 GSS (161), Veozah, APRETUDE, MOUNJARO, FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit, SHINGRIX.
Industry payments across IN — which companies pay providers there.
